PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 61 filers reported holding PRELUDE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,378 | -96.8% | 446 | -92.8% | 0.00% | – |
| Q1 2022 | $43,000 | -50.0% | 6,187 | -10.2% | 0.00% | – |
| Q4 2021 | $86,000 | -58.0% | 6,887 | +5.4% | 0.00% | – |
| Q3 2021 | $205,000 | -80.7% | 6,537 | -82.4% | 0.00% | -100.0% |
| Q2 2021 | $1,063,000 | -32.9% | 37,133 | +1.5% | 0.00% | 0.0% |
| Q1 2021 | $1,585,000 | +228.2% | 36,586 | +442.0% | 0.00% | – |
| Q4 2020 | $483,000 | – | 6,750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 10,039,691 | $313,740,000 | 3.45% |
| Baker Brothers Advisors | 10,123,824 | $316,370,000 | 1.39% |
| Logos Global Management LP | 400,000 | $12,500,000 | 0.90% |
| HHLR ADVISORS, LTD. | 583,333 | $18,229,000 | 0.24% |
| Rock Springs Capital Management LP | 362,359 | $11,324,000 | 0.24% |
| Virtus ETF Advisers LLC | 6,292 | $197,000 | 0.09% |
| FEDERATED HERMES, INC. | 408,100 | $12,753,000 | 0.02% |
| Virtu Financial LLC | 7,940 | $248,000 | 0.02% |
| UBS ASSET MANAGEMENT AMERICAS LLC | 1,483,319 | $46,353,719,000 | 0.02% |
| FMR LLC | 7,055,666 | $220,489,000 | 0.02% |